NCT06658080View on ClinicalTrials.gov

Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

November 9, 2024

Primary Completion Date

October 25, 2026

Study Completion Date

October 25, 2027

Conditions
Breast Cancer MetastaticHydrothoraxAscitesOrganoidsDrug Evaluation
Interventions
DIAGNOSTIC_TEST

organoid drug test

Before initiating therapy, patients diagnosed with metastatic breast cancer patients with hydrothorax and ascite fluid. The hydrothorax and ascite fluid is utilized to establish organoids and conduct drug testing.

Trial Locations (3)

310000

RECRUITING

Second affiliated hospital of zhejiang university, Hangzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

310009

RECRUITING

2 nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER